In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv

The emergence of multi-drug-resistant Mycobacterium tuberculosis (Mtb) strains has rendered many of the currently available anti-TB drugs ineffective. Hence, there is a pressing need to discover new potential drug targets/candidates. In this study, attempts have been made to identify novel inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurya, Satyamvada, Jain, Amita, Rehman, Md Tabish, Hakamy, Ali, Bantun, Farkad, AlAjmi, Mohamed F., Singh, Vineeta, Zehra, Aafreen, Khan, Feroz, Haque, Shafiul, Mishra, Bhartendu Nath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968056/
https://www.ncbi.nlm.nih.gov/pubmed/36838640
http://dx.doi.org/10.3390/molecules28041652

Ejemplares similares

Ejemplares similares